Total submissions: 19
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000172739 | SCV000051363 | benign | Primary dilated cardiomyopathy | 2013-06-24 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000038857 | SCV000062535 | benign | not specified | 2018-08-29 | criteria provided, single submitter | clinical testing | The p.Ala276Val variant in ANKRD1 is classified as benign because it has been de tected in 2% (212/10136) of Ashkenazi Jewish chromosomes by gnomAD (http://gnoma d.broadinstitute.org). ACMG/AMP Criteria applied: BA1. |
Eurofins Ntd Llc |
RCV000038857 | SCV000232725 | likely benign | not specified | 2015-05-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000038857 | SCV000235727 | benign | not specified | 2018-03-06 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000252792 | SCV000318911 | benign | Cardiovascular phenotype | 2017-02-23 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV001081125 | SCV000563271 | benign | ANKRD1-related dilated cardiomyopathy | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000590657 | SCV000699381 | likely benign | not provided | 2017-07-31 | criteria provided, single submitter | clinical testing | Variant summary: The ANKRD1 c.827C>T (p.Ala276Val) variant involves the alteration of a conserved nucleotide. 3/4 in silico tools predict a damaging outcome for this variant (SNPsandGO not captured due to low reliability index). In vitro functional analysis shows that this variant leads to decrease in transcriptional repression activity (Duboscq-Bidot_2009).This variant was found in 346/121722 control chromosomes (1 homozygote) including ExAC at a frequency of 0.0028425, which is approximately 83 times the estimated maximal expected allele frequency of a pathogenic ANKRD1 variant (0.0000344), suggesting this variant is likely a benign polymorphism. This variant has been reported in two siblings with DCM without strong evidence for causality (Duboscq-Bidot_2009). In addition, multiple clinical diagnostic laboratories/reputable databases have classified this variant as likely benign/benign. Taken together, this variant is currently classified as likely benign. |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000623947 | SCV000740548 | likely benign | Primary familial hypertrophic cardiomyopathy | 2017-05-23 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000614830 | SCV000743701 | likely benign | Congenital total pulmonary venous return anomaly | 2016-10-19 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000614830 | SCV000745109 | uncertain significance | Congenital total pulmonary venous return anomaly | 2015-09-21 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000770301 | SCV000901734 | likely benign | Cardiomyopathy | 2019-04-30 | criteria provided, single submitter | clinical testing | |
Center for Advanced Laboratory Medicine, |
RCV000852623 | SCV000995327 | benign | Cardiomyopathy; Systolic heart failure | 2019-04-01 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000172739 | SCV001259573 | likely benign | Primary dilated cardiomyopathy | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
ARUP Laboratories, |
RCV000590657 | SCV001471588 | benign | not provided | 2023-11-07 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000590657 | SCV004127063 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | ANKRD1: BP4, BS2 |
Diagnostic Laboratory, |
RCV000614830 | SCV000732967 | benign | Congenital total pulmonary venous return anomaly | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000038857 | SCV001924780 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000038857 | SCV001952265 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000590657 | SCV001974746 | likely benign | not provided | no assertion criteria provided | clinical testing |